AOD-9604
Symbol Ao · MW 1815 Da
C-terminal fragment of human growth hormone studied for fat metabolism.
- Discovered
- 2001
- Half-life
- 3 minutes
- Approval
- Not FDA-approved for weight loss
Reported effects
- Fat oxidation
- Cartilage support
- Lean composition
Overview
AOD-9604 is a modified peptide fragment derived from human growth hormone and is commonly researched for its potential role in fat metabolism and body composition support. Unlike full human growth hormone, AOD-9604 was designed to focus on the fat-metabolism portion of the molecule without producing the broader growth-related effects associated with HGH. It is often discussed as a weight loss peptide because of its potential influence on lipolysis, which is the breakdown of stored fat, and lipogenesis, which is the creation of new fat. AOD-9604 is commonly associated with fat loss support, metabolic health, and body recomposition, although human research remains limited compared with approved weight-management medications.
How it's taken
- Typical Administration
- Injectable / Oral
- Typical Dosage
- No established approved dosage; commonly referenced range is 250–500 mcg daily, with older oral research using 1–30 mg daily.
- Typical Frequency
- Once daily
Research sources
Source links included from peer-reviewed literature and trusted medical journal records for this peptide.
Interested in AOD-9604?
Enter your email and we'll send you a curated list of vendors we trust for sourcing this peptide.
No spam · Unsubscribe anytime
For educational purposes only. Many peptides shown are research compounds and not approved for human use in all jurisdictions.